人民网海口11月20日电 （记者崔译戈）固体饮料、口服液、压片糖果……18日，人民网多语种记者采访团走进海南华研胶原科技股份有限公司（下 称"海南华研"），各式各样的鱼胶原蛋白肽产品映入记者眼帘。在这里，海南华研通过技术创新，将鱼鳞、鱼皮等水产副产品提质转化进行再加工，生产出 高价值的胶原蛋白环二肽。 作为国家级高新技术企业、国家海洋创新示范企业，海南华研深耕鱼胶原蛋白肽领域，建立了从原料加工到成品研发的全链条核心技术体系。企业在海 口建设的鱼胶原蛋白肽产业化基地年产达4500至5000吨，产品出口全球50多个国家和地区。 海南华研海口生产基地生物多肽透明车间。海南华研胶原科技股份有限公司供图 "海南是海洋大省，丰富且优质的海洋生物资源是吸引我们的核心基础。"海南华研胶原科技股份有限公司国际业务负责人梁晓莉介绍，海南本地优质海 洋资源为公司鱼胶原蛋白肽的原料品质提供了天然保障。 近年来，海南向海洋要生产力、求新增长点，围绕"向海图强"推进海洋经济高质量发展。2024年，海南省发布《高质量发展海洋经济推进建设海洋强省 三年行动方案（2024—2026年）》，提出在2023年海洋生产总值占全省GDP比重33.8% ...

Core Viewpoint - The article highlights the innovative transformation of fish by-products into high-value bioactive peptides by Hainan Huayan, showcasing the company's commitment to research and development in the collagen peptide industry [17][18][19]. Company Overview - Hainan Huayan focuses on the deep processing of fish by-products, converting low-value materials like fish scales and skins into high-value bioactive peptide products through over 20 processing steps [17][18]. - The company provides one-stop OEM/ODM services for global brand owners, exporting products to over 50 countries and regions, including Japan and South Korea [17][18]. Research and Development - Hainan Huayan has invested significantly in R&D, dedicating 8% to 10% of its annual revenue to research, and has established partnerships with over ten research institutions [21][23]. - The company has developed a series of proprietary technologies and automated production equipment, enabling it to achieve breakthroughs in the collagen peptide sector [21][22]. Product Innovation - The flagship product, collagen peptide cyclic dipeptide, was developed after thousands of experiments, marking a significant achievement in the field and leading to the acquisition of relevant national patents [19][20]. - Hainan Huayan has successfully created a complete product system with over 120 patents and 40 enterprise standards, ensuring high product quality that competes with international counterparts [23]. Market Expansion - The company has invested nearly 200 million yuan in building a collagen peptide industrialization base, which includes two production lines with an annual capacity of 4,500 tons [25]. - Hainan Huayan aims to leverage the advantages of the Hainan Free Trade Port to explore larger market opportunities, with a reported nearly 100% growth in overseas sales in the first half of the year [26][27].

Core Viewpoint - The company, Hainan Huayan Collagen Technology Co., Ltd., has developed a method to utilize fish processing by-products, such as fish scales and skins, to produce high-value collagen peptides through enzymatic hydrolysis technology, addressing resource waste and environmental pressure in the seafood processing industry [1][2]. Group 1: Company Development and Innovation - The company has been focused on the development and utilization of marine biological resources for 20 years, achieving significant technological breakthroughs and international expansion, with products sold in over 50 countries [1][2]. - Hainan Huayan has established a world-leading marine biological peptide innovation base and has been recognized as a national high-tech enterprise [1][2]. - The company has invested 8% to 10% of its annual revenue into research and development, emphasizing the importance of enhancing its innovation capabilities for sustainable growth [5]. Group 2: Technological Advancements - The company has successfully developed a core technology for controlling biological active enzymes, which is crucial for extracting specific molecular weight peptide products [3]. - After two and a half years of research and nearly 3,000 experiments, the company achieved a breakthrough in producing a new product, cyclic dipeptide, and obtained two national patents [3]. - Collaborative research with various scientific institutions has led to significant improvements in extraction rates and product purity, achieving internationally leading technology levels [4][5]. Group 3: Market Expansion - Hainan Huayan is strategically expanding its production capacity and market presence, with plans to establish production bases in multiple locations, including Hainan and Henan, and sales centers in major cities [6]. - The company has invested in a fish collagen peptide industrialization base in Haikou, which is now the largest facility for producing marine biological peptide monomers in Asia, with an annual production capacity of 4,500 tons [6]. - A joint venture has been established in Thailand to operate a tuna peptide processing plant, marking an important step in the company's international development [6]. Group 4: Future Goals - The company aims to continuously focus on high-value utilization of marine biological resources, functional product technology research, and international market expansion, with a goal to launch 2 to 3 innovative products annually and become a leading platform for functional peptide raw material research and manufacturing by 2027 [7].

Group 1 - A company in Hainan is utilizing fish by-products such as scales, skins, and internal organs to produce high-value nutritional health products, exporting to over 50 countries and regions [1][3] - Hainan Huayan Co., Ltd. employs biocatalysis technology to process fish skins and scales into collagen peptides, achieving a comprehensive utilization of the fish [3][4] - The company has established four production bases and five sales centers nationwide, with a single factory in Haikou having an annual production capacity of 4,500 tons, making it a leader in the international market [4] Group 2 - Hainan Huayan has over 3,000 square meters dedicated to marine bio-peptide research and collaborates with more than ten universities and research institutes, holding over 120 patents [4] - The company benefits from improved customs efficiency and simplified import/export procedures under the Hainan Free Trade Port policy, which enhances its ability to enter international markets [5] - The company has developed an automated production line for medical devices, achieving a daily output of approximately 300,000 urinary catheters, with a total production of around 90 million catheters by 2024 [7]

Core Insights - The article highlights the significant role of private enterprises in China, particularly small and medium-sized enterprises (SMEs), in driving innovation and economic growth [1] - It emphasizes the importance of independent innovation for these companies to transition from followers to leaders in their respective industries [1] Company Innovations - Ounait Cable Group, based in Qinghai, has developed photovoltaic cables capable of withstanding extreme conditions, achieving an annual production of 120,000 kilometers, which could wrap around the Earth three times [1] - The company has invested 100 million yuan in a new project, aiming for a production value of 2 billion yuan next year [1] - Jiadu Technology has implemented an intelligent customer service system that handles approximately 85% of ticketing inquiries, resulting in a 106.26% year-on-year revenue growth in Q1 [1] - Hainan Huayan Collagen Technology has successfully developed a new fish collagen peptide product, with production lines capable of producing 4,500 tons annually, and has expanded its market to over 50 countries [1] Industry Trends - The article notes a trend of traditional industries moving towards high-end, intelligent, and green development, with a surge in strategic emerging industries such as artificial intelligence and robotics [1] - The vast market potential and diverse application scenarios in China are expected to provide ample opportunities for private enterprises to accelerate technological innovation and product iteration [1]

Core Viewpoint - The upcoming 2025 Shenzhen International Fisheries Expo will showcase over 20 companies from Maoming, known as the "Capital of Tilapia in China," presenting more than 100 tilapia products, highlighting the industry's response to market challenges and opportunities for expansion [6][8][11]. Group 1: Product Matrix - Maoming's tilapia industry has developed a comprehensive product matrix, with over 100 products to be displayed at the expo, including various processed and health products [15][18]. - The industry has adapted to market changes by introducing products like "skinless fish fillets" and "seasoned fish steaks" for the European and American markets, as well as pre-prepared dishes targeting younger domestic consumers [20][21][22]. - The tilapia industry in Maoming has formed a complete industrial chain, encompassing feed production, seed breeding, ecological farming, export processing, and deep processing, with an output value exceeding 100 billion yuan [25][26]. Group 2: Brand Building - During the expo, a promotional event for Maoming tilapia will be held, featuring experts and representatives discussing the brand's story and nutritional value, aiming to enhance brand recognition and market competitiveness [28][31][34]. - Maoming tilapia has received various accolades, including being recognized as a top regional agricultural brand in China, which contributes to its brand image and market appeal [36][39]. Group 3: Market Expansion - The Maoming Tilapia Association is leveraging the expo to facilitate connections between producers and domestic and international buyers, aiming to expand sales channels and market share [41][43].